Literature DB >> 9989019

Neuropsychological functioning in cocaine abusers with and without alcohol dependence.

J E Robinson1, R K Heaton, S S O'Malley.   

Abstract

Thirty codependent cocaine and alcohol users were compared with age-, education-, race-, and sex-matched cocaine abusers (N = 30) and normals (N = 30) using an extended Halstead-Reitan Neuropsychological Test Battery to determine whether cocaine abusers with alcohol dependence were more cognitively impaired than singly addicted cocaine abusers. Tests were grouped and analyzed according to 8 major ability areas. Participants who abused both cocaine and alcohol did not differ from normals on the majority of test measures. An unexpected but consistent finding was the poorer performance of the cocaine sample relative to cocaine and alcohol abusers on measures of complex psychomotor and simple motor functioning (ps < .001). Pure cocaine abusers, but not abusers of both cocaine and alcohol, also performed more poorly than normals on a measure of global neuropsychological functioning (p < .01). These results are consistent with previous reports of generally mild cognitive dysfunction in cocaine abusers. The findings also suggest that cocaine and alcohol abusers of relatively young ages may be less cognitively impaired than demographically comparable cocaine abusers. Evidence from studies of vascular functioning in abusers of cocaine and alcohol alone and in combination is discussed as possible explanation for these findings.

Entities:  

Mesh:

Year:  1999        PMID: 9989019     DOI: 10.1017/s1355617799511028

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  18 in total

Review 1.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

2.  Effects of acute and chronic cocaine administration on titrating-delay matching-to-sample performance.

Authors:  Brian D Kangas; Marc N Branch
Journal:  J Exp Anal Behav       Date:  2012-03       Impact factor: 2.468

Review 3.  Neuropsychiatric effects of cocaine use disorders.

Authors:  Charles U Nnadi; Olubansile A Mimiko; Henry L McCurtis; Jean Lud Cadet
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

4.  Conditional Effects of Lifetime Alcohol Consumption on Methamphetamine-Associated Neurocognitive Performance.

Authors:  Rowan Saloner; Emily W Paolillo; Anya Umlauf; David J Moore; Robert K Heaton; Igor Grant; Mariana Cherner
Journal:  J Int Neuropsychol Soc       Date:  2019-06-10       Impact factor: 2.892

Review 5.  Cocaine and the heart.

Authors:  M Egred; G K Davis
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

6.  Sex differences in neurocognitive functioning among abstinent recreational cocaine users.

Authors:  Qazi Rahman; Christopher David Clarke
Journal:  Psychopharmacology (Berl)       Date:  2005-10-14       Impact factor: 4.530

Review 7.  Gene expression profiling in the brains of human cocaine abusers.

Authors:  Michael Bannon; Gregory Kapatos; Dawn Albertson
Journal:  Addict Biol       Date:  2005-03       Impact factor: 4.280

8.  Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin.

Authors:  Dawn N Albertson; Barb Pruetz; Carl J Schmidt; Donald M Kuhn; Gregory Kapatos; Michael J Bannon
Journal:  J Neurochem       Date:  2004-03       Impact factor: 5.372

Review 9.  Cognitive enhancement as a pharmacotherapy target for stimulant addiction.

Authors:  Mehmet Sofuoglu
Journal:  Addiction       Date:  2010-01       Impact factor: 6.526

10.  The impacts of substance abuse and dependence on neuropsychological functions in a sample of patients from Saudi Arabia.

Authors:  Mohamed A Al-Zahrani; Yasser A Elsayed
Journal:  Behav Brain Funct       Date:  2009-12-11       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.